Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TechTissue

Financiado

TechTissue - Validate human-based 3D in vitro models for accurate drug discovery...

TechTissue - Validate human-based 3D in vitro models for accurate drug discovery and development towards a successful market entry Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks to improve 3D cell culture and disease modelling for drug discovery and... ver más

31/05/2023

METATISSUE

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

METATISSUE BIOSOLUTIONS LDA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-31

HORIZON-EIE-2021-SCALEUP-01-03: Women TechEU ExpectedOutcome:

Innovación

Cerrada hace 3 años

0% 100% 100%

1 Participantes

METATISSUE

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

HumanINK Human based bioinks to engineer physiologically relevant tis... 150K€ Cerrado

SILKink Revolutionary silk-based bioink for 3D printing of ex vivo b... 2M€ Cerrado

AnisoPlate High-throughput production of anisotropic 3D human tissue mo... 150K€ Cerrado

MAT2015-65601-R NUEVAS ESTRATEGIAS DE BIOIMPRESION PARA REGENERACION OSEA Y... 339K€ Cerrado

ProINK4D ProINK4D: Engineering Dynamic Protein Hydrogels for 4D Biopr... 181K€ Cerrado

CARDINAL CARdiac tissue Design, beating INduction, and Assessment usi... 173K€ Cerrado

Duración del proyecto: 12 meses Fecha Inicio: 2022-05-16
Fecha Fin: 2023-05-31

Líder del proyecto

METATISSUE BIOSOLUTIONS LDA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 75K€

Descripción del proyecto Metatissue is focused on the design, production and commercialization of chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks to improve 3D cell culture and disease modelling for drug discovery and development, tissue engineering, and personalized medicine advancements. Metatissue has developed a bioactive platelet-rich plasma derivative precursor that can be cured upon light exposure to form soft materials with tunable mechanical properties. Such materials provide functional support for cell growth and interact with cells to control their function, guiding the process of tissue morphogenesis. This platform is the first to offer complete human-based material for 3D cell culture and an easy-to-use solution for clinical purposes. This deep technology enables researchers to culture human cells in a physiologically relevant microenvironment for applications in cell culture research, drug screening and development, cancer research, tissue engineering, replacement of animal testing and therapeutic applications. This technology will have a significant impact on the 3D cell culture market and pharmaceutical industry by accelerating drug screening and development reducing associated costs.These materials present an alternative to the gold standard materials that are currently used in cell culture assays, which generally comprise animal-derived proteins that form a gel under corporal conditions. TechTissue intend to achieve the current Metatissue strategy by exploiting its business opportunity and setting a successful business strategy and commercialization plan based on the technical optimisation of the product, the assessed market requirements, the end-user needs and the competitor analysis.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores